Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v3.24.1.u1
NOTES PAYABLE (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 06, 2024
Jun. 01, 2023
Jul. 28, 2020
Nov. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt Instrument, Unamortized Discount         $ 2,954,390     $ 2,954,390
Interest Expense, Debt         812,000 $ 937,000    
Lenders [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt Instrument, Unamortized Discount         2,954,000      
K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt issuance cost     $ 1,244,000          
Insurance Policy [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Prepaid expenses         $ 241,967     $ 345,667
Loan Agreement [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Notes payable       $ 373,320        
Monthly principal and interest payments       $ 38,741        
Monthly loan payments term       10-month period        
Annual interest rate       8.15%        
Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Annual interest rate         13.75%      
Secured debt         $ 14,562,769      
Debt description     The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months commencing on September 1, 2022          
Debt maturity date     Aug. 01, 2024          
Debt conversion amount $ 1,125,000 $ 875,000         $ 5,000,000  
Debt conversion per share $ 7.875 $ 4.5         $ 282  
Adjustments to Additional Paid in Capital, increase in fair value of conversion option             $ 573,000  
Warrants to purchase shares of common stock, exercised 142,857 194,444 2,873          
Warrant exercisable price per share     $ 208.8          
Proceeds from Warrant Exercises     $ 472,000          
Proceeds from prepayment and default features     546,000          
Final payment     1,590,000   1,590,000      
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-Based Payment Arrangement, Tranche One [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Secured debt     $ 20,000,000          
Loan Agreement [Member] | Debt 1 [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount             2,000,000  
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount         $ 3,000,000   $ 875,000  
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share             $ 282  
Loan Agreement [Member] | Debt 1a [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share             $ 4.5  
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount             $ 1,125,000  
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member] | Minimum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share             $ 282  
Loan Agreement [Member] | Debt 1b [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion per share             $ 7.875  
Loan Agreement [Member] | Debt 2 [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt conversion amount             $ 3,000,000  
Debt conversion per share             $ 282  
Amended loan agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Debt description     The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. The Amended Loan and Security Agreement deferred the commencement of principal repayments by a one-year period from September 1, 2022 to September 1, 2023 and if the Company raises at least $30 million in net proceeds through capital raising transactions, the commencement of principal repayments will be deferred by an additional six months to March 1, 2024. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche          
Debt issuance cost     $ 119,000          
Event of Default - Loan Agreement [Member] | K2 HealthVentures LLC [Member]                
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]                
Annual interest rate         5.00%      
Debt maturity date         Aug. 01, 2024